AbbVie advances major depressive disorder ambitions for Vraylar with hopes for $4B-plus in sales - FiercePharma

Submitted by Anonymous (not verified) on Wed, 02/23/2022 - 15:35

AbbVie advances major depressive disorder ambitions for Vraylar with hopes for $4B-plus in sales  FiercePharma